Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Aspirex™ Thrombectomy System

K-Number: K230356 · 2023-03-31

Decision Date2023-03-31
Product CodeQEW
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Aspirex™ Thrombectomy System is a medical device manufactured by C.R. Bard, Inc.. It received FDA 510(k) clearance on 2023-03-31 under approval number K230356. The device is classified under product code QEW. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Aspirex™ Thrombectomy System?

Aspirex™ Thrombectomy System is a medical device that received FDA 510(k) clearance on 2023-03-31. It is manufactured by C.R. Bard, Inc.. The 510(k) number is K230356.

When was Aspirex™ Thrombectomy System approved by the FDA?

Aspirex™ Thrombectomy System received FDA 510(k) clearance on 2023-03-31, under approval number K230356.

What company makes Aspirex™ Thrombectomy System?

Aspirex™ Thrombectomy System is manufactured by C.R. Bard, Inc..

What is the FDA product code for Aspirex™ Thrombectomy System?

The FDA product code for Aspirex™ Thrombectomy System is QEW.

Related Clinical Trials

Other Devices by C.R. Bard, Inc.

View all 67 devices →

Related Devices (Code: QEW)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.